HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory.

Saved in:
Bibliographic Details
Title: HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory.
Authors: Grunwitz C; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center Mainz, Mainz, Germany., Salomon N; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany., Vascotto F; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany., Selmi A; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany., Bukur T; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany., Diken M; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany., Kreiter S; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany., Türeci Ö; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Sahin U; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany.
Source: Oncoimmunology [Oncoimmunology] 2019 Jul 11; Vol. 8 (9), pp. e1629259. Date of Electronic Publication: 2019 Jul 11 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2162-4011
DOI:10.1080/2162402X.2019.1629259